Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew J During

Showing results (101-110 of 116) with videos related to

Pageof 12
Sort By:
Science Advances|April 20, 2019
Olanzapine: A potent agonist at the hM4D(Gi) DREADD amenable to clinical translation of chemogeneticsMikail Weston, Teresa Kaserer, Angela Wu, et al.
Epilepsia|September 12, 2021
Soticlestat, a novel cholesterol 24-hydroxylase inhibitor, reduces seizures and premature death in Dravet syndrome miceNicole A Hawkins, Manuel Jurado, Tyler T Thaxton, et al.
Neurobiology of Disease|May 22, 2003
Molecular investigation of TBP allele length: a SCA17 cellular model and population studySuzanne J Reid, Mark I Rees, Willeke M C van Roon-Mom, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 5, 2017
Long-term restoration of visual function in end-stage retinal degeneration using subretinal human melanopsin gene therapySamantha R De Silva, Alun R Barnard, Steven Hughes, et al.
International Journal of Molecular Sciences|November 13, 2020
Platelet-Reactive Antibodies in Patients after Ischaemic Stroke-An Epiphenomenon or a Natural Protective MechanismYoung Eun Park, Rushi Penumarthy, Paul P Sun, et al.
Scientific Reports|October 14, 2020
Soticlestat, a novel cholesterol 24-hydroxylase inhibitor shows a therapeutic potential for neural hyperexcitation in miceToshiya Nishi, Shinichi Kondo, Maki Miyamoto, et al.
Cellular Signalling|May 19, 2015
Inhibition of glutamate regulated calcium entry into leukemic megakaryoblasts reduces cell proliferation and supports differentiationTania Kamal, Taryn N Green, Marie-Christine Morel-Kopp, et al.
Lancet (London, England)|January 21, 2014
Retinal gene therapy in patients with choroideremia: initial findings from a phase 1/2 clinical trialRobert E MacLaren, Markus Groppe, Alun R Barnard, et al.
Science Translational Medicine|December 21, 2012
Long-term follow-up after gene therapy for canavan diseasePaola Leone, David Shera, Scott W J McPhee, et al.
Platelets|March 10, 2017
Inhibition of NMDA receptor function with an anti-GluN1-S2 antibody impairs human platelet function and thrombosisTaryn N Green, Justin R Hamilton, Marie-Christine Morel-Kopp, et al.
Pageof 12

Showing results (101-110 of 116) with videos related to

Sort By:
Pageof 12
Science Advances|April 20, 2019
Olanzapine: A potent agonist at the hM4D(Gi) DREADD amenable to clinical translation of chemogeneticsMikail Weston, Teresa Kaserer, Angela Wu, et al.
Epilepsia|September 12, 2021
Soticlestat, a novel cholesterol 24-hydroxylase inhibitor, reduces seizures and premature death in Dravet syndrome miceNicole A Hawkins, Manuel Jurado, Tyler T Thaxton, et al.
Neurobiology of Disease|May 22, 2003
Molecular investigation of TBP allele length: a SCA17 cellular model and population studySuzanne J Reid, Mark I Rees, Willeke M C van Roon-Mom, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 5, 2017
Long-term restoration of visual function in end-stage retinal degeneration using subretinal human melanopsin gene therapySamantha R De Silva, Alun R Barnard, Steven Hughes, et al.
International Journal of Molecular Sciences|November 13, 2020
Platelet-Reactive Antibodies in Patients after Ischaemic Stroke-An Epiphenomenon or a Natural Protective MechanismYoung Eun Park, Rushi Penumarthy, Paul P Sun, et al.
Scientific Reports|October 14, 2020
Soticlestat, a novel cholesterol 24-hydroxylase inhibitor shows a therapeutic potential for neural hyperexcitation in miceToshiya Nishi, Shinichi Kondo, Maki Miyamoto, et al.
Cellular Signalling|May 19, 2015
Inhibition of glutamate regulated calcium entry into leukemic megakaryoblasts reduces cell proliferation and supports differentiationTania Kamal, Taryn N Green, Marie-Christine Morel-Kopp, et al.
Lancet (London, England)|January 21, 2014
Retinal gene therapy in patients with choroideremia: initial findings from a phase 1/2 clinical trialRobert E MacLaren, Markus Groppe, Alun R Barnard, et al.
Science Translational Medicine|December 21, 2012
Long-term follow-up after gene therapy for canavan diseasePaola Leone, David Shera, Scott W J McPhee, et al.
Platelets|March 10, 2017
Inhibition of NMDA receptor function with an anti-GluN1-S2 antibody impairs human platelet function and thrombosisTaryn N Green, Justin R Hamilton, Marie-Christine Morel-Kopp, et al.
Pageof 12